FIRST MIDWEST BANK TRUST DIVISION - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2019. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.

Quarter-by-quarter ownership
FIRST MIDWEST BANK TRUST DIVISION ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2021$194,000
+16.2%
41,7310.0%0.02%
+4.2%
Q3 2021$167,000
+13.6%
41,731
+21.9%
0.02%
+20.0%
Q2 2021$147,000
-61.2%
34,231
-61.7%
0.02%
-61.5%
Q1 2021$379,000
-37.4%
89,341
-42.7%
0.05%
-40.9%
Q4 2020$605,000
+412.7%
155,845
+431.2%
0.09%
+388.9%
Q3 2020$118,000
-5.6%
29,3360.0%0.02%
-10.0%
Q2 2020$125,000
-77.1%
29,336
-77.5%
0.02%
-80.0%
Q1 2020$547,000
+24.6%
130,158
+90.8%
0.10%
+66.7%
Q1 2019$439,000
-42.6%
68,216
+79.5%
0.06%
-41.7%
Q3 2018$765,000
+174.2%
38,008
+296.9%
0.10%
+164.1%
Q2 2018$279,0009,5770.04%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2019
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,018,00094.79%
TANG CAPITAL MANAGEMENT LLC 9,405,490$39,879,00011.22%
RTW INVESTMENTS, LP 2,327,903$9,870,0000.15%
Boxer Capital, LLC 890,700$3,777,0000.13%
FIRST MIDWEST BANK TRUST DIVISION 89,341$379,0000.05%
WealthTrust Axiom LLC 30,400$128,0000.04%
PREMIER ASSET MANAGEMENT LLC 51,305$217,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 18,113$77,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 39,000$165,0000.02%
Inscription Capital, LLC 10,000$42,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders